Linked Life Data

21449783

Source:http://linkedlifedata.com/resource/pubmed/id/21449783

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
13
pubmed:dateCreated
2011-3-31
pubmed:databankReference
pubmed:abstractText
Peginterferon-ribavirin therapy is the current standard of care for chronic infection with hepatitis C virus (HCV). The rate of sustained virologic response has been below 50% in cases of HCV genotype 1 infection. Boceprevir, a potent oral HCV-protease inhibitor, has been evaluated as an additional treatment in phase 1 and phase 2 studies.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1533-4406
pubmed:author
pubmed:issnType
Electronic
pubmed:day
31
pubmed:volume
364
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1195-206
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:21449783-Adult, pubmed-meshheading:21449783-African Continental Ancestry Group, pubmed-meshheading:21449783-Anemia, pubmed-meshheading:21449783-Antiviral Agents, pubmed-meshheading:21449783-Double-Blind Method, pubmed-meshheading:21449783-Drug Therapy, Combination, pubmed-meshheading:21449783-Female, pubmed-meshheading:21449783-Genotype, pubmed-meshheading:21449783-Hepacivirus, pubmed-meshheading:21449783-Hepatitis C, Chronic, pubmed-meshheading:21449783-Humans, pubmed-meshheading:21449783-Interferon-alpha, pubmed-meshheading:21449783-Male, pubmed-meshheading:21449783-Middle Aged, pubmed-meshheading:21449783-Polyethylene Glycols, pubmed-meshheading:21449783-Proline, pubmed-meshheading:21449783-RNA, Viral, pubmed-meshheading:21449783-Recombinant Proteins, pubmed-meshheading:21449783-Ribavirin, pubmed-meshheading:21449783-Serine Proteinase Inhibitors, pubmed-meshheading:21449783-Treatment Outcome, pubmed-meshheading:21449783-Viral Load
pubmed:year
2011
pubmed:articleTitle
Boceprevir for untreated chronic HCV genotype 1 infection.
pubmed:affiliation
Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA. fred.poordad@cshs.org
pubmed:publicationType
Journal Article, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase III